SCHEMBL12472147

SCHEMBL12472147

COC(=O)c1nc(C)nc(O)c1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.52
KDM4C Q9H3R0 1/20 0.43
RNASEH1 O60930 1/20 0.40
ERCC1 P07992 2/20 0.40
FEN1 P39748 2/20 0.40
ERCC4 Q92889 2/20 0.40
EGLN1 Q9GZT9 1/20 0.38
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 3/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PKM P14618 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
LMNA P02545 2/20 0.35
GAA P10253 2/20 0.35
POLB P06746 1/20 0.35
NFKB1 P19838 1/20 0.35
XDH P47989 1/20 0.35
GFER P55789 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1150688 0.77 NPSR1 (0.48) NPSR1KDM4CRNASEH1ERCC1FEN1
SCHEMBL4913697 0.77 EGLN1 (0.41) RNASEH1ERCC1FEN1ERCC4EGLN1
SCHEMBL1150589 0.75 NPSR1 (0.42) NPSR1KDM4CRNASEH1KDM4EALDH1A1
SCHEMBL24800386 0.75 NPSR1 (0.42) NPSR1KDM4CRNASEH1ERCC1FEN1
SCHEMBL24801218 0.75 NPSR1 (0.42) NPSR1KDM4CRNASEH1EGLN1KDM4E
SCHEMBL13998902 0.73 NPSR1 (0.54) NPSR1KDM4CEGLN1KDM4EALDH1A1
SCHEMBL4907155 0.73 ALDH1A1 (0.50) NPSR1ERCC1FEN1ERCC4KDM4E
SCHEMBL4920425 0.73 NPSR1 (0.44) NPSR1KDM4CRNASEH1ERCC1FEN1
SCHEMBL13041238 0.72 NPSR1 (0.42) NPSR1KDM4CRNASEH1ERCC1FEN1
SCHEMBL11732441 0.71 NPSR1 (0.56) NPSR1KDM4CRNASEH1ERCC1FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119371360-A 5, 6-Dihydroxypyrimidine compound and preparation method and application thereof 暨南大学 2025-01-28 CN disclosed
US-20150218120-A1 HIV INTEGRASE INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-08-06 US disclosed
US-20140142137-A1 HIV INTEGRASE INHIBITORS NATIONAL INSTITUTES OF HEALTH (US) 2014-05-22 US disclosed
WO-2012106534-A2 HIV INTEGRASE INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140142137-A1 HIV INTEGRASE INHIBITORS IMPDH1, TYMP, IMPA1 NPSR1 4674/4885KDM4C 2491/4885RNASEH1 772/4885
US-20150218120-A1 HIV INTEGRASE INHIBITORS IMPDH1, TYMP, IMPA1 NPSR1 4674/4885KDM4C 2491/4885RNASEH1 772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.